Background: previous studies have reported volatile organic compounds (VOCs) in the
breath as apparent biomarkers of lung cancer. We tested the hypothesis that a robust breath …

Background Breath volatile organic compounds (VOCs) have been reported as biomarkers
of lung cancer, but it is not known if biomarkers identified in one group can identify disease …

Background: Normal metabolism generates several volatile organic compounds (VOCs) that
are excreted in the breath (eg alkanes). In patients with lung cancer, induction of high-risk …

Simple Summary Human-exhaled volatile organic compounds (VOCs) can be altered by
lung cancer and become identifiable biomarkers. We used selected ion flow tube mass …

There has been an increased focus on the development of non-invasive biomarkers capable
of accurately identifying lung cancer early in its course and characterizing the nature of the …

Study objectives To evaluate volatile organic compounds (VOCs) in the breath as tumor
markers in lung cancer. Alkanes and monomethylated alkanes are oxidative stress products …

Background The exhaled breath of lung cancer patients contains volatile organic
compounds (VOCs) that differ from those in healthy individuals. These VOCs can be …

Breath analysis is a promising technique for lung cancer screening. Despite the rapid
development of breathomics in the last four decades, no consistent, robust, and validated …

Lung cancer is one of the leading causes of cancer incidence and cancer-related deaths in
the world. Early diagnosis of pulmonary tumors results in improved survival compared to …

Lung cancer, chronic obstructive pulmonary disease (COPD) and asthma are inflammatory
diseases that have risen worldwide, posing a major public health issue, encompassing not …